85 related articles for article (PubMed ID: 19551902)
1. Pathway sensitivity analysis for detecting pro-proliferation activities of oncogenes and tumor suppressors of epidermal growth factor receptor-extracellular signal-regulated protein kinase pathway at altered protein levels.
Li H; Ung CY; Ma XH; Liu XH; Li BW; Low BC; Chen YZ
Cancer; 2009 Sep; 115(18):4246-63. PubMed ID: 19551902
[TBL] [Abstract][Full Text] [Related]
2. Computational modelling reveals feedback redundancy within the epidermal growth factor receptor/extracellular-signal regulated kinase signalling pathway.
Orton RJ; Sturm OE; Gormand A; Wolch W; Gilbert DR
IET Syst Biol; 2008 Jul; 2(4):173-83. PubMed ID: 18681747
[TBL] [Abstract][Full Text] [Related]
3. Automated oncogene detection in complex protein networks with applications to the MAPK signal transduction pathway.
Pant D; Ghosh A
Biophys Chem; 2005 Mar; 113(3):275-88. PubMed ID: 15620513
[TBL] [Abstract][Full Text] [Related]
4. Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells.
Ushio K; Hashimoto T; Kitamura N; Tanaka T
Mol Cancer Res; 2009 Jul; 7(7):1179-88. PubMed ID: 19567783
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor receptor is involved in clusterin-induced astrocyte proliferation.
Shim YJ; Shin YJ; Jeong SY; Kang SW; Kim BM; Park IS; Min BH
Neuroreport; 2009 Mar; 20(4):435-9. PubMed ID: 19218870
[TBL] [Abstract][Full Text] [Related]
6. A hidden oncogenic positive feedback loop caused by crosstalk between Wnt and ERK pathways.
Kim D; Rath O; Kolch W; Cho KH
Oncogene; 2007 Jul; 26(31):4571-9. PubMed ID: 17237813
[TBL] [Abstract][Full Text] [Related]
7. Simulation of crosstalk between small GTPase RhoA and EGFR-ERK signaling pathway via MEKK1.
Li H; Ung CY; Ma XH; Li BW; Low BC; Cao ZW; Chen YZ
Bioinformatics; 2009 Feb; 25(3):358-64. PubMed ID: 19074159
[TBL] [Abstract][Full Text] [Related]
8. The impact of the regulatory design on the response of epidermal growth factor receptor-mediated signal transduction towards oncogenic mutations.
Wolf J; Dronov S; Tobin F; Goryanin I
FEBS J; 2007 Nov; 274(21):5505-17. PubMed ID: 17916191
[TBL] [Abstract][Full Text] [Related]
9. A systems biology approach for the study of cumulative oncogenes with applications to the MAPK signal transduction pathway.
Pant DK; Ghosh A
Biophys Chem; 2006 Jan; 119(1):49-60. PubMed ID: 16185809
[TBL] [Abstract][Full Text] [Related]
10. Troglitazone inhibits cell proliferation by attenuation of epidermal growth factor receptor signaling independent of peroxisome proliferator-activated receptor gamma.
Li X; Yang X; Xu Y; Jiang X; Li X; Nan F; Tang H
Cell Res; 2009 Jun; 19(6):720-32. PubMed ID: 19417774
[TBL] [Abstract][Full Text] [Related]
11. Influence of kinetics of drug binding on EGFR signaling: a comparative study of three EGFR signaling pathway models.
Bairy S; Wong CF
Proteins; 2011 Aug; 79(8):2491-504. PubMed ID: 21638335
[TBL] [Abstract][Full Text] [Related]
12. Effect of epidermal growth factor receptor inhibitor alone and in combination with cisplatin on growth of vulvar cancer cells.
Kim SH; Song YC; Kim SH; Jo H; Song YS
Ann N Y Acad Sci; 2009 Aug; 1171():642-8. PubMed ID: 19723115
[TBL] [Abstract][Full Text] [Related]
13. Epidermal-growth-factor-induced proliferation of astrocytes requires Egr transcription factors.
Mayer SI; Rössler OG; Endo T; Charnay P; Thiel G
J Cell Sci; 2009 Sep; 122(Pt 18):3340-50. PubMed ID: 19706684
[TBL] [Abstract][Full Text] [Related]
14. A reduction of epidermal growth factor receptor is involved in brefelamide-induced inhibition of phosphorylation of ERK in human astrocytoma cells.
Honma S; Saito M; Kikuchi H; Saito Y; Oshima Y; Nakahata N; Yoshida M
Eur J Pharmacol; 2009 Aug; 616(1-3):38-42. PubMed ID: 19559020
[TBL] [Abstract][Full Text] [Related]
15. Insect cytokine growth-blocking peptide signaling cascades regulate two separate groups of target genes.
Ninomiya Y; Kurakake M; Oda Y; Tsuzuki S; Hayakawa Y
FEBS J; 2008 Mar; 275(5):894-902. PubMed ID: 18215168
[TBL] [Abstract][Full Text] [Related]
16. Overactivation of the MEK/ERK pathway in liver tumor cells confers resistance to TGF-{beta}-induced cell death through impairing up-regulation of the NADPH oxidase NOX4.
Caja L; Sancho P; Bertran E; Iglesias-Serret D; Gil J; Fabregat I
Cancer Res; 2009 Oct; 69(19):7595-602. PubMed ID: 19773433
[TBL] [Abstract][Full Text] [Related]
17. Sustained activation of glial cell epidermal growth factor receptor by bis(thiosemicarbazonato) metal complexes is associated with inhibition of protein tyrosine phosphatase activity.
Price KA; Caragounis A; Paterson BM; Filiz G; Volitakis I; Masters CL; Barnham KJ; Donnelly PS; Crouch PJ; White AR
J Med Chem; 2009 Nov; 52(21):6606-20. PubMed ID: 19807095
[TBL] [Abstract][Full Text] [Related]
18. [The influence of the EGF on proliferative signal transduction in ciliate Tetrahymena pyriformis].
Shemarova IV; Selivanova GV; Vlasova TD
Tsitologiia; 2007; 49(2):156-60. PubMed ID: 17432601
[TBL] [Abstract][Full Text] [Related]
19. Nuclear autoantigen CENP-B transactivation of the epidermal growth factor receptor via chemokine receptor 3 in vascular smooth muscle cells.
Robitaille G; Christin MS; Clément I; Senécal JL; Raymond Y
Arthritis Rheum; 2009 Sep; 60(9):2805-16. PubMed ID: 19714638
[TBL] [Abstract][Full Text] [Related]
20. Targeting MAPK (Ras/ERK) and PI3K/Akt pathways in pituitary tumorigenesis.
Cakir M; Grossman AB
Expert Opin Ther Targets; 2009 Sep; 13(9):1121-34. PubMed ID: 19637976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
